inter
The first urine test to predict preeclampsia months in advance.
Featured News - May 1, 2026
Savran Technologies Presents Preeclampsia Data at 2026 ACOG Annual Clinical & Scientific Meeting
Featured News - March 28, 2026
Savran Technologies Presents Breakthrough Preeclampsia Data at Society for Reproductive Investigation Annual Meeting (SRI 2026)
Featured News - January 12, 2026
Savran Technologies Receives FDA Breakthrough Device Designation for Urine-Based Assay for Early Risk Stratification of Preeclampsia
SavranTech develops diagnostics for critical conditions in women’s health
Our mission is to revolutionize women’s health diagnostics through non-invasive tests that provide reliable screening at the earliest actionable time, powered by our patented ultra-rare cell detection platform.
The Problem & Detection Gap
Preeclampsia is a serious, potentially life-threatening pregnancy complication characterized by high blood pressure and organ dysfunction, typically emerging after 20 weeks of gestation.
Impact on mothers:
• Affects 1 in 12 pregnancies worldwide.
• If undetected, can rapidly escalate to seizures, stroke, organ failure, or even maternal death.
Significant threat to babies:
• Leading cause of preterm birth, responsible for 15% of premature deliveries globally.
• Higher risks of growth restriction, respiratory complications, developmental delays, and neonatal death.
Global impact: Preeclampsia affects over 10 million women each year and is a leading cause of maternal and fetal mortality worldwide, contributing to more than 500,000 infant deaths annually.
Late detection: Current screening methods are indirect, nonspecific, and often too late for effective intervention.
Unmet need: There is urgent demand for early, non-invasive, and clinically actionable detection.
Our Solution
“The optimal window to begin aspirin prophylaxis for preeclampsia prevention is between 12 and 16 weeks of gestation.”
— American College of Obstetricians and Gynecologists (ACOG)
Simple urine test: Detect upstream biomarkers directly related to preeclampsia
1st trimester detection: As early as 10 weeks GA
Full pregnancy coverage: Test anytime from 10 weeks to delivery
Predicts all forms of preeclampsia
Straightforward report, no complexity
Tests for Better Outcomes
Early detection improves clinical decision-making by enabling timely interventions, leading to better maternal and neonatal outcomes, and raising the standard in maternal health.